Keywords: Germany, Medicines access, Assesment model, AMNOG, Price comparisons, EFPIA, VFA

German model for assessment of new medicines slammed by EU pharma leaders

Article | 11 June 2012

Leading pharmaceutical companies in Europe, represented in the European Federation of Pharmaceutical Industries and Associations (EFPIA), meeting in Berlin last ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in